| Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design N Gasper-Smith, DM Crossman, JF Whitesides, N Mensali, JS Ottinger, ... Journal of virology 82 (15), 7700-7710, 2008 | 123 | 2008 |
| NK cells specifically TCR-dressed to kill cancer cells N Mensali, P Dillard, M Hebeisen, S Lorenz, T Theodossiou, MR Myhre, ... EBioMedicine 40, 106-117, 2019 | 65 | 2019 |
| Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity N Mensali, A Grenov, NB Pati, P Dillard, MR Myhre, G Gaudernack, ... Oncoimmunology 8 (3), 1558663, 2019 | 29 | 2019 |
| Rab7b regulates dendritic cell migration by linking lysosomes to the actomyosin cytoskeleton K Vestre, I Persiconi, M Borg Distefano, N Mensali, NA Guadagno, ... Journal of Cell Science 134 (18), jcs259221, 2021 | 19 | 2021 |
| Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials EB Ellingsen, E Aamdal, T Guren, W Lilleby, PF Brunsvig, SM Mangsbo, ... Journal for Immunotherapy of Cancer 10 (5), 2022 | 18 | 2022 |
| Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy N Mensali, MR Myhre, P Dillard, S Pollmann, G Gaudernack, G Kvalheim, ... Cancer Immunology, Immunotherapy 68, 1235-1243, 2019 | 15 | 2019 |
| Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei K Flatmark, A Torgunrud, KG Fleten, B Davidson, HV Juul, N Mensali, ... Journal for immunotherapy of cancer 9 (10), 2021 | 12 | 2021 |
| T cells raised against allogeneic HLA‐A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells IW Abrahamsen, S Kjellevoll, M Greve‐Isdahl, N Mensali, S Wälchli, ... International journal of cancer 130 (8), 1821-1832, 2012 | 11 | 2012 |
| ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma N Mensali, H Köksal, S Joaquina, P Wernhoff, NP Casey, P Romecin, ... Nature Communications 14 (1), 3375, 2023 | 9 | 2023 |
| Human c-SRC kinase (CSK) overexpression makes T cells dummy EM Inderberg, N Mensali, MP Oksvold, LE Fallang, A Fåne, G Skorstad, ... Cancer Immunology, Immunotherapy 67, 525-536, 2018 | 9 | 2018 |
| “Built‐in” PD‐1 blocker to rescue NK‐92 activity from PD‐L1–mediated tumor escape mechanisms N Mensali, P Dillard, A Fayzullin, H Köksal, G Gaudernack, G Kvalheim, ... The FASEB Journal 35 (9), e21750, 2021 | 8 | 2021 |
| Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA N Mensali, F Ying, VOY Sheng, W Yang, E Walseng, S Kumari, ... Oncoimmunology 5 (5), e1138199, 2016 | 7 | 2016 |
| Emerging biomarkers for immunotherapy in glioblastoma N Mensali, EM Inderberg Cancers 14 (8), 1940, 2022 | 6 | 2022 |
| NK cells specifically TCR-dressed to kill cancer cells. EBioMedicine 40: 106–117 N Mensali, P Dillard, M Hebeisen, S Lorenz, T Theodossiou, MR Myhre, ... CrossRef PubMed PubMed Central, 2019 | 6 | 2019 |
| Unpredicted phenotypes of two mutants of the TcR DMF5 FG Tadesse, N Mensali, LE Fallang, E Walseng, W Yang, J Olweus, ... Journal of Immunological Methods 425, 37-44, 2015 | 5 | 2015 |
| Induction of plasma (TRAIL), TNFR-2, Fas ligand and plasma microparticles after HIV-1 transmission: implications for HIV-1 vaccine design N Gasper-Smith, D Crossman, J Whitesides, N Mensali, J Ottinger, ... J Virol 82, 7700-10, 2008 | 5 | 2008 |
| SIMPLIFIED METHOD TO OPTIMIZE REAGENTS FOR AN 11-COLOR (13-MARKER) POLYCHROMATIC INTRACELLULAR STAINING (ICS) PANEL JS Ottinger, N Mensali, E Jennifer, AK Weinhold, KJ Weinhold CYTOMETRY PART B-CLINICAL CYTOMETRY 74 (6), 373-373, 2008 | 2 | 2008 |
| Invariant chain with an AP3 interacting sorting signal is sorted to late endosomal compartments and may improve MHC class I loading and presentation A Kucera, N Mensali, NB Pati, EM Inderberg, MR Myhre, TF Gregers, ... BioRxiv, 2020.05. 13.091579, 2020 | 1 | 2020 |
| Correction to: preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy N Mensali, MR Myhre, P Dillard, S Pollmann, G Gaudernack, G Kvalheim, ... Cancer Immunology, Immunotherapy 69, 159-161, 2020 | 1 | 2020 |
| Compositions and Methods for Cell Therapy S Walchli, EM Inderberg, G Kvalheim, G Gaudernack, N Mensali US Patent App. 16/467,400, 2019 | 1 | 2019 |
